US 11872261
Lipoprotein targeting protease inhibitors and uses
granted A61KA61K38/005A61K38/07
Quick answer
US patent 11872261 (Lipoprotein targeting protease inhibitors and uses) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/005, A61K38/07, A61K38/08, A61K38/10